Clinical Trial Update: Prevention of Postoperative Bleeding in Subcapital Femoral Fractures [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating prevention of postoperative bleeding in subcapital femoral fractures has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hip Fracture

Snippet

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Conditions: Hip Fracture, Blood Loss | Phase 3 | Status: COMPLETED